Allovir, Inc.·4

Oct 5, 9:05 PM ET

Melian Agustin 4

4 · Allovir, Inc. · Filed Oct 5, 2021

Insider Transaction Report

Form 4
Period: 2021-10-04
Melian Agustin
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2021-10-04$24.23/sh4,711$114,129456,829 total
  • Sale

    Common Stock

    2021-10-04$23.29/sh10,678$248,690461,540 total
  • Sale

    Common Stock

    2021-10-04$25.41/sh2,967$75,377453,862 total
  • Sale

    Common Stock

    2021-10-04$26.02/sh333$8,666453,529 total
Footnotes (5)
  • [F1]Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock, and does not represent a discretionary trade by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.78 to $23.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.78 to $24.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.78 to $25.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.795 to $26.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION